The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria

Blood

Volumn 87, Issue 12, 1996, Pages 5332-5340

  Hall, Sharon E ^a   Rosse, Wendell F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SCHOOL CHILD; SERODIAGNOSIS; THROMBOCYTE;

EID: 0029981029     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5332.bloodjournal87125332     Document Type: Article

References (48)

1. Rosse WF: Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood 75:1595, 1990
2. Yeh ETH, Rosse WF: Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor. J Clin Invest 93:2305, 1994
3. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T: Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703, 1993
4. Holguin MH, Frederick LR, Bernshaw NJ, Wilcox LA, Parker CJ: Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 84:7, 1989
5. Meri S, Waldmann H, Lachmann PJ: Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest 65:532, 1991
6. Davies A, Simmons DL, Hale G, Harrison RA, Tighe H, Lachmann PJ, Waldmann H: CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170:637, 1989
7. Sugita Y, Nakano Y, Oda E, Noda K, Tobe T, Miura NH, Tomita M: Determination of carboxyl-terminal residue and disulfide bonds of MACIF (CD59), a glycosyl-phosphatidylinositol-anchored membrane protein. J Biochem (Tokyo) 114:473, 1993
8. Nicholson-Weller A, March JP, Rosenfeld SI, Austen KF: Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci USA 80:5430, 1983
9. Rosse WF, Dacie JV: Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest 45:736, 1966
10. Rosse WF, Adams JP, Thorpe AM: The population of cells in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis: Significance and mechanism of increased immune lysis. Br J Haematol 28:181, 1974
11. van der Schoot CE, Huizinga TW, van't Veer-Korthof ET, Wijmans R, Pinkster J, von dem Borne AE: Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria; description of a new diagnostic cytofluorometric assay. Blood 76:1853, 1990
12. Schubert J, Alvarado M, Uciechowski P, Zielinska Skowronek M, Freund M, Vogt H, Schmidt RE: Diagnosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells. Br J Haematol 79:487, 1991
13. Rosse WF, Hoffman S, Campbell M, Borowitz M, Moore JO, Parker CJ: The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis. Br J Haematol 79:99, 1991
14. Shichishima T, Terasawa T, Hashimoto C, Ohto H, Uchida T, Maruyama Y: Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes. Br J Haematol 78:545, 1991
15. Shichishima T, Terasawa T, Saitoh Y, Hashimoto C, Ohto H, Maruyama A: Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-color flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Br J Haematol 85:378, 1993
16. Kwong YL, Lee CP, Chan TK, Chan LC: Flow cytometric measurement of glycosylphosphatidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria. Am J Clin Pathol 102:30, 1994
17. Kooyman D, Byrne G, McClellan S, Nielsen D, Kagan D, Coffman T, Masahide T, Waldmann H, Platt J, Logan J: Erythroid-specific expression of human CD59 and transfer to vascular endothelial cells. Transplant Proc 26:1241, 1994
18. Stern M, Rosse WF: Two populations of granulocytes in paroxysmal nocturnal hemoglobinuria. Blood 53:928, 1979
19. Brubaker L, Essig LJ, Mengel CE: Neutrophil life span in paroxysmal nocturnal hemoglobinuria. Blood 50:657, 1977
20. Rosse WF: The life-span of complement-sensitive and -insensitive red cells in paroxysmal nocturnal hemoglobinuria. Blood 37:556, 1971
21. Ware RE, Rosse WF, Howard TA: Mutations within the Pig-a gene in patients with paroxysmal nocturnal hemoglobinuria. Blood 83:2418, 1994
22. Bessler M, Mason PJ, Hillmen P, Luzzatto L: Mutations in the PIG-A gene causing partial deficiency of GPI-linked surface proteins (PNH II) in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 87:863, 1994
23. Schubert J, Uciechowski P, Delany P, Tischler HJ, Kolanus W, Schmidt RE: The PIG-anchoring defect in NK lymphocytes of PNH patients. Blood 76:1181, 1990
24. Tseng JE, Hall SE, Ware RE: Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria. Am J Hematol 50:244, 1995
25. Masuda T, Yonoemura Y, Fujimoto K, Hidaka M, Nagakura S, Nakakuma H, Hata H, Samada O, Takatsuki T: Establishment of a human T-cell line with deficient surface expression of glycosylphosphatidylinositol (GPI)-anchored proteins from a patient with paroxysmal nocturnal haemoglobinuria. Br J Haematol 87:24, 1994
26. Nakakuma H, Nagakura S, Horikawa K, Hidaka M, Kawaguchi T, Iwamoto N, Sanada I, Kagimoto T, Takatsuki K: Interleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients. Blood 84:309, 1994
27. Hillmen P, Bessler M, Mason PJ, Watkins WM, Luzzatto L: Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 90:5272, 1993
28. Hillmen P, Bessler M, Crawford DH, Luzzatto L: Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype. Blood 81:193, 1993
29. Bessler M, Mason PJ, Hillmen P, Miyata T, Yameda N, Takeda J, Luzzatto L, Kinoshita T: Paroxysmal nocturnal hemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 13:110, 1994
30. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV: Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333:1253, 1995
31. Nakakuma H, Nagakura S, Iwamoto N, Kawaguchi T, Hidaka M, Horikawa K, Kagimoto T, Shido T, Takatsuki K: Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia. Blood 85:1371, 1995
32. de Planque MM, Bacigalupo A, Wursch A, Hows JM, Devergie A, Frickhofen N, Brand A, Nissen C: Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT). Br J Haematol 73:121, 1989
33. Antin JR, Ginsburg D, Smith BR, Nathan DG, Orkin SH, Rappeport JM: Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: Eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. Blood 66:1247, 1985
34. Kruatrachue M, Na-Nakorn S: Transient paroxysmal nocturnal hemoglobinuria during the course of aplastic anemia. J Med Assoc Thai 57:427, 1974
35. Schubert J, Vogt HG, Zielinska-Skowronek M, Freund M, Kaltwasser JP, Hoelzer D, Schmidt RE: Development of the glycosylphosphatidylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood 83:2323, 1994
36. Nissen C, Moser Y, dalle Carbonare V, Gratwohl A, Speck B: Complete recovery of marrow function after treatment with anti-lymphocyte globulin is associated with high, whereas early failure and development of paroxysmal nocturnal haemoglobinuria are associated with low endogenous G-CSA-release. Br J Haematol 72:573, 1989
37. Najean Y, Haguenauer O: Long-term (5 to 20 years) evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias. Blood 76:2222, 1990
38. Fujioka S, Yamada T: Decay accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia. Br J Haematol 83:660, 1993
39. Dacie JV, Lewis SM: Paroxysmal nocturnal haemoglobinuria: Variation in clinical severity and association with bone marrow hypoplasia. Br J Haematol 7:442, 1961
40. Lewis SM, Dacie JV: The aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol 13:236, 1967
41. Rosse WF: Paroxysmal nocturnal hemoglobinuria, in Rosse WF (ed): Clinical Immunohematology: Basic Concepts and Clinical Applications, Boston, Blackwell Scientific Publications, 1990, p 593
42. May JE, Rosse W, Frank MM: Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium. N Engl J Med 289:705, 1973
43. Crookston JH, Crookston MC, Rosse WF: Red-cell abnormalities in HEMPAS (hereditary erythroblastic multinuclearity with a positive acidified-serum test). Br J Haematol 23:83, 1972 (suppl)
44. Hartmann RC, Jenkins DEj: The "sugar water" test for paroxysmal nocturnal hemoglobinuria. New Engl J Med 275:155, 1996
45. Sirchia G, Ferrone S, Mercuriali F: In vitro lysis of AET-treated normal red cells (PNH-like cells) by normal and cirrhotic sera. Brit J Haematol 17:245, 1969
46. Reid ME, Mallinson G, Sim RB, Poole J, Pausch V, Merry AH, Liew YW, Tanner MJ: Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency). Blood 78:3291, 1991
47. Tate CG, Uchikawa M, Tanner MJ, Judson PA, Parsons SF, Mallinson G, Anstee DJ: Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype. Biochem J 261:489, 1989
48. Yamashina M, Ueda E, Kinoshita T, Takami T, Ojima A, Ono H, Tanaka H, Kondo N, Orii T, Okada N, Okada H, Inoue K, Kitani T: Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med 323:1184, 1990